Ameliorated estrogen-induced cholestasis via Farnesoid X receptor signaling and improved inflammatory gene expressionSuppression of pro-inflammatory NF-κB, TNF-α and IL-1βActivation of Nrf2 in neuronal PC-12 and astroglial C6 cells. The gene discussed is NFKB1; the disease is cholestasis.